Guanhao Biotech Co.,Ltd. (300238.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.67B
Enterprise Value3.64B
P/E Ratio185.85
PEG Ratio-5.21
Price/Sales Ratio8.77
Price/Book Ratio5.43
Enterprise/Revenue8.74
Enterprise/EBITDA88.8

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.05
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue383.42M
Revenue/Share1.36
Gross Profit278.77M
EBITDA57.66M
Net Income24.35M
Diluted EPS0.09

Balance Sheet

Total Cash145.76M
Total Cash/Share0.55
Total Debt135.19M
Total Debt/Equity0.23
Current Ratio2.06
Book Value Per Share1.87

Price History

52-Week Change-21.74
52-Week High18
52-Week Low10.19
Moving Average 50 Days11.52
Moving Average 200 Days13.57

Statistics

Average Volume5.92M
Shares Outstanding265.16M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.16
Last Split Factor2:1
Last Split DateApril 16, 2015
AD